Biolase Technology, Inc. (BIOL) Earnings
|
Expand Research on BIOL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -18.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/8/24 | Q224 | -$0.08 | $0.00 | -$0.08 | $11.56M | N/A | N/A | ![]() | ![]() | Details | |
| 11/9/23 |
Q323 | -$3.89 | -$2.33 | -$1.56 | $10.92M | $15.52M | N/A | ![]() | ![]() | Details | |
| 8/10/23 | Q223 | -$4.24 | -$5.33 | +$1.09 | $14.3M | $15.36M | N/A | ![]() | ![]() | Details | |
| 5/11/23 | Q123 | -$0.18 | -$0.14 | -$0.04 | $10.5M | $12.23M | N/A | ![]() | ![]() | Details | |
| 3/28/23 | Q422 | -$1.28 | -$0.66 | -$0.62 | $14.1M | $13.58M | N/A | ![]() | ![]() | Details | |
| 3/8/23 | Q422 | N/A | -$0.66 | N/A | N/A | $13.58M | N/A | N/A | N/A | ||
| 11/10/22 | Q322 | -$1.10 | -$0.63 | -$0.47 | $12.01M | $10.53M | N/A | ![]() | ![]() | Details | |
| 8/11/22 | Q222 | -$0.91 | -$0.64 | -$0.27 | $12.2M | $10.63M | N/A | ![]() | ![]() | Details |


